Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
05/2004
05/06/2004EP1414788A1 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists
05/06/2004EP1163237B1 Amide derivatives
05/05/2004CN1494530A Heterocyclic diamide invertebrate pest control agents
05/05/2004CN1493291A Dicyclic compound capable of inhibiting epidermis growth factor acceptor rotatory tyrosine kinase
05/05/2004CN1148361C Oxyiminoalkanoic acid derivatives
05/05/2004CN1148356C Benzosulfone derivatives
05/05/2004CN1148346C Hydrazine derivs.
05/04/2004US6730787 Viricides, immunostimulants, antitubercular, anticarcinogenic, antitumor, antidepressant, antichlamydial, and analgesic agents; psychological disorders
05/04/2004US6730783 Reacting aminoguanidine with carbonyl compound to form amidinohydrazone; reduction; reacting with alkoxyamine; guanidinylation; anticoagulants
05/04/2004US6730705 Alkoximino acetic acid amides
04/2004
04/29/2004WO2004035569A2 Novel compounds with antibacterial activity
04/29/2004WO2004035556A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
04/29/2004WO2004035525A1 Inhibitors of histone deacetylase
04/29/2004WO2004034967A2 2,4,6-triaminopyrimidines for the treatment of depression and/or anxiety
04/29/2004WO2004019868A3 N-biarylmethyl aminocycloalkanecarboxamide derivatives
04/29/2004WO2003093242A3 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
04/29/2004WO2003086282A3 Nitric oxide donors, compositions and methods of use
04/29/2004WO2002079169A8 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
04/29/2004WO2002078626A3 Therapeutic combinations for cardiovascular and inflammatory indications
04/29/2004US20040082786 Piperazine based inhibitors of factor xa
04/29/2004US20040082780 Vanilloid receptor ligands and their use in treatments
04/29/2004US20040082779 Melanocortin-4 receptor binding compounds and methods of use thereof
04/29/2004US20040082627 Certain aromatic monocycles as kinase modulators
04/29/2004US20040082625 Osteoporosis, bone disorders
04/29/2004US20040082611 Novel sulfonyl derivatives
04/29/2004US20040082587 2,4,6-Triaminopyrimidines for the treatment of depression and/or anxiety
04/29/2004US20040082585 Anticoagulants; controlling thrombosis; cardiovascular disorders
04/29/2004US20040082576 Cardiovascular disorders; anticancer agents; antidiabetic agents; dietetics
04/29/2004US20040082553 Novel florfenicol-type antibiotics
04/29/2004CA2502249A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
04/29/2004CA2501265A1 Inhibitors of histone deacetylase
04/29/2004CA2500320A1 Novel compounds with antibacterial activity
04/28/2004EP1413578A1 Novel crystal of arylethenesulfonamide derivative and process for producing the same
04/28/2004EP1413300A1 Pyrimidinium-guanidiniminoethylphenyl-guanidinoalkyl-amines and guanidiniminoethylphenyl-guanidinoalkylamines as pharmaceutically active new substances
04/28/2004EP1412515A2 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists
04/28/2004EP1412364A1 Platelet adp receptor inhibitors
04/28/2004EP1412355A1 New pyrazolo(3,4-d)pyrimidines inhibiting h. pylori infections
04/28/2004EP1412327A2 Inhibitors of protein kinase for the treatment of disease
04/28/2004EP1411993A2 Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy
04/28/2004EP1411929A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
04/28/2004EP1150962B1 Process for the preparation of 6-(perfluoroalkyl)uracil compounds from carbamate compounds
04/28/2004EP0840741B1 Pna-dna chimeras and pna synthons for their preparation
04/28/2004EP0558648B1 Improved matrix metalloprotease inhibitors
04/28/2004EP0513200B2 Method and compositions for the synthesis of bch-189 and related compounds
04/28/2004CN1492864A Pyrazolyl pyrimidines
04/28/2004CN1492860A 喹唑啉衍生物 Quinazoline derivatives
04/28/2004CN1492859A Pyrimidine acyclonucleoside derivatives, preparation method and use thereof
04/28/2004CN1491937A 农药 Pesticide
04/28/2004CN1147481C Pyrimidine-2,4,6-triones as inhibitors of matrix metalloproteinases
04/28/2004CN1147480C Technological process of producing orotic acid
04/28/2004CN1147479C 2-pyrimidyloxybenzyl substituted naphthyl amine derivative and its synthesis and use
04/27/2004US6727257 Hypotensive agents for intraocular pressure; anticholesterol agents; relaxing urinary tract tissue; benign prostatic hyperplasia, impotency, and cardiovascular disorders; antiarrhythmia agents
04/27/2004US6727256 4-aminoquinazoline derivatives as anticarcinogenic agents
04/27/2004US6727053 Forms an azomethine dye upon a coupling reaction with an oxidized product of a developing agent
04/27/2004CA2136745C Heterocyclically disubstituted sulphonylamino(thio)carbonyl compounds
04/22/2004WO2004033435A1 Quinazolinone derivatives useful as anti-hyperalgesic agents
04/22/2004WO2004032931A1 Method for treatment of cancer
04/22/2004WO2004016597A3 Protein kinase inhibitors and uses thereof
04/22/2004WO2003082263A8 Sulfamic acids as inhibitors of human cytoplasmic protein tyrosine phosphatases
04/22/2004WO2003041728A9 Novel phenyl-propargylether derivatives
04/22/2004WO2000061134A9 Antimicrobial agents
04/22/2004US20040077875 (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2 -thiazolyl)carbamic Acid, 1,1-dimethylethyl ester for example; treating immunological and oncological disorders such as inflammatory bowel disease or cancer
04/22/2004US20040077671 Sorbitol dehydrogenase inhibitors
04/22/2004US20040077670 Novel sulfamides and their use as endothelin receptor antagonists
04/22/2004US20040077669 Pyrimidine compounds and their use
04/22/2004US20040077667 Quinazolinone derivatives
04/22/2004US20040077662 Compounds, methods and compositions
04/22/2004US20040077647 Fluorinated di-aryl urea compounds
04/22/2004US20040077642 Pyrimidine compounds
04/22/2004US20040075096 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
04/22/2004CA2501529A1 Quinazolinone derivatives useful as anti-hyperalgesic agents
04/21/2004EP1411048A1 Preparation of 2-bromo-pyrimidines and 2-iodo-pyrimidines
04/21/2004EP1411046A1 QUINOLINE DERIVATIVE AND QUINAZOLINE DERIVATIVE INHIBITING SELF−PHOSPHORYLATION OF HEPATOCYTUS PROLIFERATOR RECEPTOR, AND MEDICINAL COMPOSITION CONTAINING THE SAME
04/21/2004EP1409707A2 Method for obtaining useful products from organisms
04/21/2004EP1409463A1 N-heterocyclic inhibitors of tnf-alpha expression
04/21/2004EP1409462A1 Method for producing 4-methyl pyrimidine
04/21/2004EP1409456A2 Detection of transmembrane potentials by optical methods
04/21/2004EP1409450A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
04/21/2004EP1409440A1 A method to inhibit ethylene responses in plants
04/21/2004EP1408980A2 Novel quinazolines and uses thereof
04/21/2004EP1408978A2 Novel phenylamino-pyrimidines and uses thereof
04/21/2004EP1228039B1 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
04/21/2004EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
04/21/2004CN1491208A Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical
04/21/2004CN1491207A Acylated indanyl amines and their use as pharmaceuticals
04/21/2004CN1491200A Process for manufacture of phenylacetic acid derivatives
04/21/2004CN1491106A Treatment of oesophageal motility disorders and gastro-oesophageal reflux disease
04/21/2004CN1146566C 2-aryl-8-oxodihydropurine derivatives, process for producing same, medicinal conty, same, and intermediates thereof
04/21/2004CN1146560C Substituted benzoylpyrazoles as herbicides
04/21/2004CN1146550C Halogenated pyrimidines and its application as method for reducing parasite
04/21/2004CN1146547C Process for preparation of 4,6-dicloro-5-fluoropyrimidine
04/21/2004CN1146543C Serine protease inhibitor
04/21/2004CN1146542C Benzamide derivatives and their use as cytokine inhibitors
04/21/2004CN1146541C Beta-alanine derivatives
04/21/2004CN1146536C Cycloethylene derivatives
04/21/2004CN1146467C Cyclic carbamide surfactant
04/20/2004US6723753 Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
04/15/2004WO2004031405A1 Substrates for o6-alkylguanine-dna alkyltransferase
04/15/2004WO2004031180A1 Quinazolin-4-one derivatives
04/15/2004WO2004031161A1 Neurologically-active compounds